Publications by authors named "Brigette B B Y Ma"
Progress in the clinical development of investigational systemic agents for recurrent and metastatic nasopharyngeal carcinoma.
Expert Opin Investig Drugs
October 2024
Article Synopsis
- Nasopharyngeal carcinoma (NPC) is a prevalent disease in some regions, often diagnosed at an advanced stage, with traditional chemotherapy showing limited progress until recently.
- Recent advancements include investigational treatments like anti-vascular agents, signaling pathway inhibitors, and immunotherapies that are being explored for advanced NPC.
- The incorporation of immune-checkpoint inhibitors into standard chemotherapy has transformed first-line treatment options, with ongoing research into new combinations and maintenance therapies for improved outcomes in subsequent treatment lines.